Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 30;7(9):001630.
doi: 10.12890/2020_001630. eCollection 2020.

Erdheim-Chester Disease: A Rare Clinical Entity

Affiliations

Erdheim-Chester Disease: A Rare Clinical Entity

Margarida Oliveira et al. Eur J Case Rep Intern Med. .

Abstract

Pericardial effusion represents a diagnostic challenge. Erdheim-Chester disease (ECD), though a rare cause, should be considered in the differential diagnosis. An 88-year-old woman was admitted to the hospital due to retrosternal pain, dyspnoea and constitutional symptoms. Hypoxaemic respiratory failure and increased inflammatory markers were documented. A chest x-ray revealed an increased cardiothoracic ratio. An echocardiogram showed a moderate-volume pericardial effusion, without signs of cardiac tamponade. A thoraco-abdomino-pelvic CT scan found a bilateral perirenal soft tissue halo. Perirenal mass biopsy showed diffuse infiltration by foamy histiocytes (CD68+), without IgG4, compatible with ECD. The correlation of anamnesis, radiology and histology is crucial for the diagnosis of ECD.

Learning points: Erdheim-Chester disease is a non-Langerhans cell histiocytosis that affects multiple organs and systems.Thorough study of a pericardial effusion is important as it is still considered idiopathic in 10-20% of cases.It is a rare disease so high diagnostic suspicion is important. The diagnosis is established through clinical manifestations, radiologic findings and histological confirmation.

Keywords: Erdheim-Chester disease; pericardial effusion; retroperitoneal space.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interests: The Authors declare that there are no competing interests.

Figures

Figure 1
Figure 1
Coated aorta (soft tissue halo around the aorta)
Figure 2
Figure 2
CT scan showing a soft tissue halo around both kidneys (red arrows) and bilateral hydronephrosis. The kidneys had a normal size and differentiation
Figure 3
Figure 3
Bone scintigraphy – bilateral femoral hyperactivity
Figure 4
Figure 4
(A) Dispersed multinucleated histiocytes with foamy cytoplasm. (B) Foamy histiocytes with CD68 immunoreactivity
Figure 5
Figure 5
Clinical manifestations of Erdheim-Chester disease

References

    1. Houston BA, Miller PE, Rooper LM, Scheel PJ, Gelber AC. From dancing to debilitated. N Engl J Med. 2016;374(5):470–477. - PubMed
    1. Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124(4):483–492. - PMC - PubMed
    1. Alexiou J, Klastersky J. Erdheim-Chester disease: a case report. Am J Case Rep. 2015;16:361–366. - PMC - PubMed
    1. Mazor RD, Manevich-Mazor M, Shoenfeld Y. Erdheim-Chester Disease: a comprehensive review of the literature. Orphanet J Rare Dis. 2013;8(1):137. - PMC - PubMed
    1. Ponsiglione A, Puglia M, Barbuto L, Solla R, Altiero M, Lubrano V, et al. Cardiac involvement in Erdheim-Chester disease: MRI findings and literature revision. Acta Radiol Open. 2015;4(9):2058460115592273. - PMC - PubMed

LinkOut - more resources